Difficult transmembrane protein targets for therapeutic antibodies

FHS
July 12, 2023
6:48 am

In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies.

Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to Supply Special Access Program | Psychedelic Invest

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved

September 7, 2023

Finerenone shows promise for heart failure with mildly reduced or preserved ejection fraction

Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients

September 2, 2024

AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine – Pharmaceutical Technology

Share this article Parkinson’s disease is caused by a loss of nerve cells in part of the brain. Credit: Ocskay Mark via Shutterstock. US-based biotech

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.